Otsuka's Voyxact faces rival as FDA okays Vera IgAN drug
From the article
Otsuka's Voyxact faces rival as FDA okays Vera IgAN drug Phil.Taylor Wed, 08/07/2026 - 09:56
Continue reading on pharmaphorumYou might also wanna read
Sanofi to Stop Disparaging Rival Flu Vaccine to Stave Off EU Antitrust Fine
Medscape·20h ago
AstraZeneca pens $2.1B Sino deal for challenger to Merck’s COPD drug Ohtuvayre
Fierce Biotech·22h ago
Parham Habibzadeh: How the COMPETE Trial Could Reshape Treatment Sequencing for Progressive GEP-NETs
OncoDaily·4h ago
STAT+: FDA approves Vera Therapeutics kidney disease treatment
STAT·1d ago
[Trial of device that is not approved or cleared by the U.S. FDA]
clinicaltrials.gov·3d ago
Sciwind has two Western partners for its obesity drug, but is open to more
endpoints.news·26d ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.